| Summary: | 博士 === 元智大學 === 管理研究所 === 96 === In the knowledge society innovation plays a key role in determining a firm’s competitive advantage. Simultaneously inter-organizational R&D collaborations have grown over the last decade. These two factors combined place alliance’s contribution to the innovative capabilities of the firm as an important question within competitive advantage studies. The effects between the governance structure of R&D alliance and its innovative performance is, however, not well understood. Through a review of the literature I develop a contingency model from combing the transaction cost economics (TCE), real option (RO), resorce-based view (RBV) and knowledge based view (KBV) for research purposes. The purpose of this study is to find the factors influcing inter-firm innovative performance and the relationships among these factors. The data collecting from global biopharmaceutical alliance and patent database (1976~2006) were used in exploratory and confirmatory phases to evaluate the instruments and test the hypotheses. The conclusions are listed as below:
1. The effect of the level of inter-firm organizational interdependence in an international R&D collaboration will be nonlinear; their jointly innovative performance will increase up to an optimal level beyond which higher levels of inter-firm organizational interdependence will lead to a decline in innovative performance.
2. Firms that collaborate with science-based knowledge organizations have better innovative performance than those that collaborate with non-science-based knowledge organizations.
3. An increase in the level of the interfirm’s organizational interdependence will increase the joint innovation value.
4. Firms that collaborate with science-based knowledge organizations have lower inter-organizational interdependence than those that collaborate with non-science-based knowledge organizations.
5. The inter-organizational interdependence in an international R&D collaboration is inversely related to the level of intellectual property rights protection in the home country of its partner.
6. The level of inter-organizational interdependence in an international R&D collaboration is positively related to the level of suitability of social institution in the home country of the partner.
7. Greater resource co-specialization increases the likelihood that more interdependent inter-organizational governance forms will be used.
8. Higher technological uncertainty reduces the likelihood that inter-organizational governance forms will be interdependent.
9. Higher innovation stage uncertainty increases the likelihood that more interdependent inter-organizational governance forms will be used.
|
|---|
